Clinical Trials in San Francisco

Showing 9561-9580 of 12,991 trials

Dose-Escalation Study of GSK2126458

NCT00972686

P3K112826 is a Phase I, first-time-in-human dose escalation study in subjects with refractory malignancy. The primary objective of this study is to determine the recommended Phase II dose of GSK2126458 based on safety and tolerability, pharmacokinetics, pharmacodynamics and preliminary evidence of clinical activity. Secondary objectives are to characterize the pharmacokinetics of GSK2126458; and to explore relationships between GSK2126458 pharmacokinetics, pharmacodynamics, response prediction biomarkers and clinical endpoints.

Solid Tumours

GlaxoSmithKline79 participantsStarted Aug 2009

San Francisco, California, United States • New Brunswick, New Jersey, United States • Chapel Hill, North Carolina, United States +6 more locations

COMPLETEDNA< 1 mile

The Effect of a Novel Audit and Feedback Bundle on Inpatient Performance

NCT02593253

This single-blinded, cluster randomized control trial will assess the effectiveness of an audit and feedback bundle on internal medicine physician performance on selected quality metrics. The feedback bundle includes an electronic dashboard and weekly feedback rounds in which physicians will review their performance. The control arm will undergo audit and feedback per the current system, which is biweekly feedback emails with performance.

Quality Improvement

University of California, San Francisco200 participantsStarted Feb 2016

San Francisco, California, United States

Dose-Escalation Study of GSK2126458

The Effect of a Novel Audit and Feedback Bundle on Inpatient Performance

Find Trials by Condition in San Francisco

Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer

Tobacco Status Project: Social Media Intervention for Young Adult Smokers

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling of Ampicillin and Gentamicin in Peripartum Patients

TMS for CRPS - Pilot Study

Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique

Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents

Geodon in Weight Loss Study for Bipolar Disorders

Lactic Acidosis During and After Seizures

Thermal Compression Device for Maintenance of Perioperative Normothermia

Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics

A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares

Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma